[Treatment of patients with resistant urogenital infection].

Abstract

In our trial 43 patients with urogenital infections resistant to standard therapy received the same basic therapy (4 tablets of safocid a day for 5 days) which, on demand, was combined with pathogenetic and symptomatic treatment. The effect was achieved by both subjective and objective parameters: pathogenic microflora was not detected after 10 days in 39 (90.7%) patients; none of the patients discharged protozoa, fungi. Tests for chlamidia were negative in all the carriers in 2 months, for ureaplasma--in 94.1% males and 83.3% females, respectively. A significant response was observed in 38 of 43 (88.4%) patients, improvement was seen in 5 (11.6%) patients. The above results persisted for 2 months of follow-up.

• Authors: E V Kul'chavenia, A A Breusov
• Journal: Urologiia (Moscow, Russia : 1999) (Urologiia) 2011 Jan-Feb Issue 1 Pg. 17-21 ISSN: 1728-2985 [Print] Russia (Federation)
• PMID: 21504073 (Publication Type: English Abstract, Journal Article)

Chemical References

• Anti-Infective Agents

Topics

• Adult
• Anti-Infective Agents (administration & dosage, adverse effects, therapeutic use)
• Drug Resistance, Multiple (drug effects)
• Female
• Female Urogenital Diseases (drug therapy, microbiology, parasitology)
• Humans
• Male
• Male Urogenital Diseases (drug therapy, microbiology, parasitology)
• Middle Aged
• Sexually Transmitted Diseases (drug therapy, microbiology, parasitology)
• Treatment Outcome
• Young Adult